Treatment, Medication & Supplement Directory
A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.
Lomustine (CCNU) in Veterinary Oncology: Delayed-Toxicity Safety Profile
Lomustine, also called CCNU, is an oral nitrosourea chemotherapy drug used by veterinary oncologists for selected cancers. Use in dogs and cats is generally extra-label and requires a…
Read more
Multimodal Pain Management in Canine Cancer Care
Multimodal pain management combines approaches that act at different points in the pain pathway and addresses both the tumor and its functional consequences. A plan may include prescriptions,…
Read moreMetronomic Chemotherapy: Goal, Evidence, and Handling Boundary
Metronomic therapy uses regularly scheduled cytotoxic medication in selected plans; it remains prescription hazardous-drug treatment and is not simply gentle chemotherapy.
Read moreHome Handling of Oral Chemotherapy and Patient Waste
Families need drug-specific written instructions for receiving, storing, administering, cleaning, laundering, and disposing of chemotherapy and contaminated patient waste.
Read more
Named profile I’m-Yunity PSP: Canine Product ProfileRepresentative category illustration – no product packaging is shown.I’m-Yunity PSP: Canine Product Profile
I'm-Yunity is a named branded product for Dogs; manufacturer positioning must be kept separate from independent clinical evidence.
Read more
Named profile Acid-Suppression Medicines in Veterinary Oncology: Rational-Use ProfileRepresentative category illustration – no product packaging is shown.Acid-Suppression Medicines in Veterinary Oncology: Rational-Use Profile
proton-pump inhibitors and histamine-2 receptor antagonists is covered as gastrointestinal supportive-medicine class, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read more
Named profile MOPP and LOPP for Canine Lymphoma: Distinct Alkylator-Rich ProtocolsRepresentative category illustration – no product packaging is shown.MOPP and LOPP for Canine Lymphoma: Distinct Alkylator-Rich Protocols
MOPP and LOPP multi-agent chemotherapy is covered as alkylator-rich canine lymphoma protocols, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read more